The FDA (Food and Drug Administration) is holding a hearing this week in the US to consider a controversial new IFV technology that would involve the creation of test-tube babies, using the DNA from 3 separate people.
The procedure aims at preventing potentially fatal mitochondrial diseases.
Read Full Article »